Testing Begins On Nasal Alzheimer's Vaccine

The video discusses a nasal vaccine being tested at Brigham and Women's Hospital to prevent and slow Alzheimer's disease. Sixteen participants aged 60 to 85 with early symptoms will receive two doses a week apart. The study aims to assess the vaccine's safety and its impact on white blood cell count.

What new insight or understanding did you gain from this video?